Literature DB >> 10226934

Midbrain dopaminergic neurons are protected from radical induced damage by GDF-5 application. Short communication.

P Lingor1, K Unsicker, K Krieglstein.   

Abstract

Embryonic day 14 rat midbrain cultures were kept for 7 days in vitro and then intoxicated with radical donors iron and sodium-nitroprusside for 24 h. Tyrosine-hydroxylase positive neurons in cultures which were additionally treated with growth/differentiation factor-5 (GDF-5) survived to a significantly higher percentage as compared to sister cultures without factor supplementation. Since the degeneration of TH positive cells is a key feature in Parkinson's disease, GDF-5 might be a putative therapeutical agent for this disorder.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226934     DOI: 10.1007/s007020050146

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  15 in total

1.  Echinacoside Protects Against MPP(+)-Induced Neuronal Apoptosis via ROS/ATF3/CHOP Pathway Regulation.

Authors:  Qing Zhao; Xiaoyan Yang; Dingfang Cai; Ling Ye; Yuqing Hou; Lijun Zhang; Jiwei Cheng; Yuan Shen; Kaizhe Wang; Yu Bai
Journal:  Neurosci Bull       Date:  2016-07-18       Impact factor: 5.203

Review 2.  Roles for the TGFβ superfamily in the development and survival of midbrain dopaminergic neurons.

Authors:  Shane V Hegarty; Aideen M Sullivan; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2014-02-07       Impact factor: 5.590

3.  Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo.

Authors:  J Strelau; A Sullivan; M Böttner; P Lingor; E Falkenstein; C Suter-Crazzolara; D Galter; J Jaszai; K Krieglstein; K Unsicker
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

Review 4.  The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: relevance to Parkinson's disease treatment.

Authors:  Aideen M Sullivan; Gerard W O'Keeffe
Journal:  J Anat       Date:  2005-09       Impact factor: 2.610

5.  GnRH-mediated DAN production regulates the transcription of the GnRH receptor in gonadotrope cells.

Authors:  Rakel López de Maturana; Bronwen Martin; Robert P Millar; Pamela Brown; Lindsay Davidson; Adam J Pawson; Moira R Nicol; J Ian Mason; Perdita Barran; Zvi Naor; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

6.  Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease.

Authors:  Daniel J Costello; Gerard W O'Keeffe; Fiona M Hurley; Aideen M Sullivan
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

7.  Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease.

Authors:  Lars Tönges; Tobias Frank; Lars Tatenhorst; Kim A Saal; Jan C Koch; Éva M Szego; Mathias Bähr; Jochen H Weishaupt; Paul Lingor
Journal:  Brain       Date:  2012-10-19       Impact factor: 13.501

8.  Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons.

Authors:  J C Koch; F Bitow; J Haack; Z d'Hedouville; J-N Zhang; L Tönges; U Michel; L M A Oliveira; T M Jovin; J Liman; L Tatenhorst; M Bähr; P Lingor
Journal:  Cell Death Dis       Date:  2015-07-09       Impact factor: 8.469

9.  Viral vector-mediated downregulation of RhoA increases survival and axonal regeneration of retinal ganglion cells.

Authors:  Jan Christoph Koch; Lars Tönges; Uwe Michel; Mathias Bähr; Paul Lingor
Journal:  Front Cell Neurosci       Date:  2014-09-05       Impact factor: 5.505

10.  GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia.

Authors:  Walter Maetzler; Willy Deleersnijder; Valérie Hanssens; Alice Bernard; Kathrin Brockmann; Justus Marquetand; Isabel Wurster; Tim W Rattay; Lorenzo Roncoroni; Eva Schaeffer; Stefanie Lerche; Anja Apel; Christian Deuschle; Daniela Berg
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.